Roche’s Glofitamab and Dizal’s Sunvozertinib Enter Priority Review
The Center for Drug Evaluation (CDE) website indicates that Swiss giant Roche’s (SWX: ROG) glofitamab...
China Optimizes Medical Insurance Policies for COVID-19 Treatment
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center...
China Resources Biopharmaceutical Secures RMB 600 Million in Series B Funding
China Resources Biopharmaceutical Co., Ltd has announced the completion of a Series B financing round,...
Adagene’s ADG126 Shows Promise in Combination with Anti-PD-1 Therapy
China-based biotech Adagene Inc. (NASDAQ: ADAG), which also operates out of San Diego, California, has...
Pfizer CEO Denies Licensing Paxlovid to Chinese Generics Firms
Pfizer Inc. (NYSE: PFE) CEO Albert Bourla, speaking on the sidelines of the JPMorgan Healthcare...
Legend Biotech Receives Nasdaq Notice Regarding Listing Compliance
Legend Biotech Corporation (NASDAQ: LEGN) announced on January 6, 2023, that it received a notice...
Jiangxi Jemincare’s JMKX003142 Gets FDA Nod for Clinical Study
China-based Jiangxi Jemincare Group has announced receiving approval from the US Food and Drug Administration...
Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
The National Reimbursement Drug List (NRDL) negotiations have concluded, with Pfizer’s (NYSE: PFE) COVID-19 therapy...
China Strengthens COVID-19 Prevention and Control in Rural Areas
China has intensified its COVID-19 prevention and control measures in rural areas, with the State...
Eli Lilly’s Donanemab Set to Gain Breakthrough Therapy Designation in China
The Center for Drug Evaluation (CDE) website indicates that US-based Eli Lilly’s (NYSE: LLY) injectable...
Changzhou Sifary Medtech Secures Series B Funding for Global Expansion
Changzhou Sifary Medical Technology Co., Ltd, a China-based platform for the globalization of oral medical...
Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA
China-based Suzhou Thery Pharmaceutical Inc. has announced that the National Medical Products Administration (NMPA) has...
Zhifei Biological Products’ BCG Vaccine Filing Accepted by China’s NMPA
China-based Chongqing Zhifei Biological Products Co., Ltd (SHE: 300122) has announced that its clinical trial...
Yantai Dongcheng Pharma Gets FDA Go-Ahead for 177Lu-LNC1004 Clinical Trial
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving approval from the...
VivaVision Biotech Partners with Everads Therapy for Retinal Disease Therapies
China’s VivaVision Biotech Inc. has announced a collaboration agreement with Israel-based Everads Therapy Ltd to...
Shenzhen-Based Rhegen Bio Raises RMB 100 Million in Pre-Series B Round
Shenzhen-based biotechnology company Rhegen Bio, specializing in mRNA technology, has reportedly raised RMB 100 million...
Hainan Poly Pharm’s Generic Ganciclovir Approved in Denmark
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced receiving marketing approval from the...
Jacobio Pharma Doses First Patient in US Phase I/IIa Study for JAB-2485
China-based Jacobio Pharma (HKG: 1167) has announced that the first patient has been dosed in...
VACSERA in Talks with Sinovac to Establish Integrated Vaccine Plant
Egypt-based drug firm Holding Company for Biological Products and Vaccines (VACSERA) is reportedly in talks...